Company intelligence / Profile preview

TheraFluor

Beaverton, Oregon, United Statestheraflu.com ↗

Ownership: Private
Development stage: Preclinical

Overview

TheraFluor is pioneering a proprietary nanomedicine platform designed for targeted cancer detection, fluorescence-guided surgery, and phototherapy. The company aims to maximize patient benefit while minimizing side effects. Its technology is being developed for both human and veterinary applications. Clinical results have not yet been published or are in very early stages.

Therapeutic areas: Oncology
Modalities: NanomedicinesFluorescent agents for imaging and therapyPhototherapy agents
Industry: Biotech

Partnerships

Oregon State University (foundational intellectual property/licensing/collaboration)Advisory network includes key inventors and veterinary experts from Oregon State University

Beyond the preview

Go deeper on TheraFluor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraFluor.

Explore the full profile